Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
Thamer Sliwa(Hanusch Hospital), Heinz Gisslinger(Medical University of Vienna), Peter Krippl, Alois Lang(Landeskrankenhaus Feldkirch), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Albert Wölfler(Medical University of Graz), Stefan Wöhrer(Fachhochschule Wiener Neustadt), Klaus Geißler(University of Vienna), Christine Beham‐Schmid(Medical University of Graz), Günther Gastl(Innsbruck Medical University), Sonja Burgstaller(Klinikum Wels-Grieskirchen), Maria Theresa Krauth(Medical University of Vienna), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern)
Cited by 9
Related Papers
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
|The Journal of Experimental Medicine|1984|1.1k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450